Appropriate diuretic dosing: Closed loop communication

Journal of Hospital Medicine

Volumn 7, Issue 3, 2012, Pages 167-169

  Barsuk, Jeffrey H ^a   Paparello, James ^a   Cotts, William ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE; FUROSEMIDE; LOOP DIURETIC AGENT; TORASEMIDE;

ACUTE HEART FAILURE; CLINICAL PROTOCOL; CONTINUOUS INFUSION; DIURETIC THERAPY; DOSE RESPONSE; DRUG DOSE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MONITORING; DRUG RESPONSE; DRUG SAFETY; DRUG USE; EDITORIAL; FOLLOW UP; HEART FAILURE; HEART OUTPUT; HUMAN; HYPOTENSION; META ANALYSIS (TOPIC); PRIORITY JOURNAL; URINE VOLUME;

FEMALE; FUROSEMIDE; HEART FAILURE; HUMANS; INFUSIONS, INTRAVENOUS; MALE;

EID: 84857797593     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.1000     Document Type: Editorial

References (13)

1. US Food and Drug Administration. FDA Approved Drug Products. Available at:. Accessed May 2, 2011.
2. Amer M, Adomaityte J, Qayyum R. Continuous infusion with intermittent bolus injections of furosemide in patients hospitalized with acute decompensated heart failure: a metaanalysis of randomized control trials. J Hosp Med. 2011;7:270-275.
3. Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011; 364: 797-805.
4. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977-2016.
5. Brater DC. Diuretic therapy. N Engl J Med. 1998; 339: 387-395.
6. Elsevier. Clinical Pharmacology. Available at:. Accessed April 18, 2011.
7. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005; 46: e1-e82.
8. O'Leary KJ, Buck R, Fligiel HM, et al. Structured interdisciplinary rounds in a medical teaching unit: improving patient safety. Arch Intern Med. 2011; 171: 678-684.
9. Hasselblad V, Gattis Stough W, Shah MR, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail. 2007; 9: 1064-1069.
10. Peacock WF, Costanzo MR, De Marco T, et al. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology. 2009; 113: 12-19.
11. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006; 47: 76-84.
12. Belknap SM, Moore H, Lanzotti SA, et al. Application of software design principles and debugging methods to an analgesia prescription reduces risk of severe injury from medical use of opioids. Clin Pharmacol Ther. 2008; 84: 385-392.
13. Peacock WF, Remer EE, Aponte J, Moffa DA, Emerman CE, Albert NM. Effective observation unit treatment of decompensated heart failure. Congest Heart Fail. 2002; 8: 68-73.